Home > Qtrly Results > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Quarterly Results Analysis [Jun2026]

SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Quarterly Results

Consolidated Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Revenues ₹15,300 Cr ₹14,612 Cr ₹15,521 Cr ₹14,478 Cr ₹13,851 Cr ₹12,959 Cr ₹13,675 Cr ₹13,291 Cr
Expenses ₹10,882 Cr ₹10,658 Cr ₹10,726 Cr ₹10,382 Cr ₹9,550 Cr ₹9,243 Cr ₹9,666 Cr ₹9,481 Cr
Operating Income ₹4,418 Cr ₹3,954 Cr ₹4,795 Cr ₹4,097 Cr ₹4,302 Cr ₹3,716 Cr ₹4,009 Cr ₹3,811 Cr
Other Income ₹724 Cr ₹459 Cr ₹733 Cr ₹900 Cr ₹464 Cr ₹613 Cr ₹466 Cr ₹482 Cr
Interest ₹100 Cr ₹86 Cr ₹78 Cr ₹100 Cr ₹75 Cr ₹49 Cr ₹52 Cr ₹69 Cr
Depreciation ₹739 Cr ₹775 Cr ₹732 Cr ₹730 Cr ₹701 Cr ₹664 Cr ₹631 Cr ₹626 Cr
Profit Before Tax ₹4,099 Cr ₹3,551 Cr ₹4,227 Cr ₹4,168 Cr ₹3,173 Cr ₹3,254 Cr ₹3,476 Cr ₹3,598 Cr
Profit After Tax ₹2,911 Cr ₹2,724 Cr ₹3,401 Cr ₹3,137 Cr ₹2,303 Cr ₹2,161 Cr ₹2,918 Cr ₹3,031 Cr
EPS ₹12.07 ₹11.31 ₹14.04 ₹13.00 ₹9.50 ₹8.96 ₹12.10 ₹12.67
Industry Peers & Returns1W1M1Y
SUN PHARMACEUTICAL INDUSTRIES 0.8% 6.3% 18.2%
DIVIS LABORATORIES 8.6% 20.7% 18.5%
TORRENT PHARMACEUTICALS 1.7% 9.4% 38.5%
CIPLA 4.5% 1.2% -1.4%
DR REDDYS LABORATORIES -0.3% -14.8% -9.5%
MANKIND PHARMA -3.2% -0.7% -0.4%
LUPIN 0.2% 0.6% 24.5%
ZYDUS LIFESCIENCES 1.7% 2.4% 14.9%
AUROBINDO PHARMA 2% 1.2% 41.5%

SUN PHARMACEUTICAL INDUSTRIES Quarterly Revenues

Revenues
Q-o-Q

4.71 %

Y-o-Y

10.46 %

Quarters Revenues % Change
Jun2026 ₹15,300 Cr
4.71
Mar2026 ₹14,612 Cr
-5.86
Dec2025 ₹15,521 Cr
7.20
Sep2025 ₹14,478 Cr
4.53
Jun2025 ₹13,851 Cr
6.89
Mar2025 ₹12,959 Cr
-5.24
Dec2024 ₹13,675 Cr
2.89
Sep2024 ₹13,291 Cr -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Operating Profit

Operating Profit
Q-o-Q

11.72 %

Y-o-Y

2.70 %

Quarters Operating Profit % Change
Jun2026 ₹4,418 Cr
11.72
Mar2026 ₹3,954 Cr
-17.53
Dec2025 ₹4,795 Cr
17.04
Sep2025 ₹4,097 Cr
-4.77
Jun2025 ₹4,302 Cr
15.76
Mar2025 ₹3,716 Cr
-7.31
Dec2024 ₹4,009 Cr
5.20
Sep2024 ₹3,811 Cr -
Operating Margins
Q-o-Q

6.69 %

Y-o-Y

-7.05 %

Quarters Operating Margin% % Change
Jun2026 28.87%
6.69
Mar2026 27.06%
-12.40
Dec2025 30.89%
9.19
Sep2025 28.29%
-8.92
Jun2025 31.06%
8.30
Mar2025 28.68%
-2.18
Dec2024 29.32%
2.27
Sep2024 28.67% -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

6.87 %

Y-o-Y

26.41 %

Quarters Profit After Tax % Change
Jun2026 ₹2,911 Cr
6.87
Mar2026 ₹2,724 Cr
-19.92
Dec2025 ₹3,401 Cr
8.42
Sep2025 ₹3,137 Cr
36.24
Jun2025 ₹2,303 Cr
6.57
Mar2025 ₹2,161 Cr
-25.94
Dec2024 ₹2,918 Cr
-3.73
Sep2024 ₹3,031 Cr -
PAT Margins
Q-o-Q

2.04 %

Y-o-Y

14.44 %

Quarters PAT Margin(%) % Change
Jun2026 19.02 %
2.04
Mar2026 18.64 %
-14.92
Dec2025 21.91 %
1.11
Sep2025 21.67 %
30.39
Jun2025 16.62 %
-0.30
Mar2025 16.67 %
-21.85
Dec2024 21.33 %
-6.45
Sep2024 22.8 % -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

6.72 %

Y-o-Y

27.05 %

Quarters EPS % Change
Jun2026 ₹12.07
6.72
Mar2026 ₹11.31
-19.44
Dec2025 ₹14.04
8.00
Sep2025 ₹13
36.84
Jun2025 ₹9.5
6.03
Mar2025 ₹8.96
-25.95
Dec2024 ₹12.1
-4.50
Sep2024 ₹12.67 -

You may also like the below Video Courses